The Hindu Business Line : Zydus Cadila in pact with Italian group

THE Gujarat-based Zydus Cadila has signed a memorandum of understanding with Italy's Zambon group for collaboration in several segments, including R&D.

The agreement spans a range of activities in the pharmaceutical segment including contract manufacturing of fine chemicals, active pharmaceutical ingredients and finished formulations and marketing of pharmaceutical products, a company release said.

"Both companies will undertake co-development of niche molecules and new generics, development of key intermediates, and R&D in fine chemicals to capitalise on the first-to-enter advantage," it added.

The company will also conduct clinical trials for Phase I and II of new chemical entities of Zambon.

Further, the Zambon group would outsource its requirements of key intermediates and finished dosage forms, and provide technical support for custom synthesis of various advanced intermediates.

This would open up a revenue stream for the Zydus group, the release said.

The alliance also incorporates co-operation in regulatory processes and IPR-related matters, besides covering the marketing of generics and ethical drugs in Europe and India.

More Stories on : Alliances & Joint Ventures | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Novartis research centre: It's a toss-up between India, China

FFE Minerals bags Rs 358-cr order from Vedanta

Mukesh says CMD is final authority — Reliance director Bhakta resigns

Chamber urges Govt to restore tax benefit on ECB interest payments

SRL Ranbaxy concludes pathological trials for 2 foreign hospitals

Salem Steel Plant gets award for QMS

Samsung to double India workforce

Indian Hotels plans resort in Munnar

ACC to invest Rs 370 cr to expand capacity

Steelbird plans expansion

BoI loan to buy Greaves tillers

Zydus Cadila in pact with Italian group

TNPL to buy hardwood from TAFCORN

Matrix Labs firms up profit sharing pact with US firms